2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)

被引:0
|
作者
S Yokota
T Imagawa
T Miyamae
K Kasai
M Mori
N Nishimoto
T Kishimoto
机构
[1] Yokohama City University,
[2] Osaka University,undefined
关键词
Corticosteroid; Respiratory Tract Infection; Juvenile Idiopathic Arthritis; Gastroenteritis; Tocilizumab;
D O I
10.1186/1546-0096-6-S1-S1
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis
    Brunner, Hermine, I
    Ruperto, Nicolino
    Ramanan, Athimalaipet, V
    Horneff, Gerd
    Minden, Kirsten
    Penades, Inmaculada Calvo
    Alexeeva, Ekaterina
    Cleary, Gavin
    Stern, Sara M.
    Kone-Paut, Isabelle
    Velazquez, Maria del Rocio Maldonado
    Rabinovich, C. Egla
    Remesal, Agustin
    Silva, Clovis Artur
    Nikishina, Irina
    Zucchetto, Mauro
    Brockwell, Laura
    Gordon, Oliver
    Nagel, Sandra
    De Benedetti, Fabrizio
    RHEUMATOLOGY, 2024, : 2535 - 2546
  • [2] Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
    Horneff G.
    Huppertz I.
    Haas P.
    Minden K.
    Ganser G.
    Hospach A.
    Trauzeddel R.
    Pediatric Rheumatology, 13 (Suppl 1)
  • [3] Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
    E Alexeeva
    R Denisova
    S Valieva
    T Bzarova
    K Isayeva
    T Sleptsova
    E Mitenko
    Pediatric Rheumatology, 9 (Suppl 1)
  • [4] Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
    O Nemiche
    R Dagner
    P Quartier
    R Cimaz
    O Richer
    P Pillet
    M Hofer
    Pediatric Rheumatology, 9 (Suppl 1)
  • [5] Efficacy and Safety of Tocilizumab in Patients with Severe Systemic Juvenile Idiopathic Arthritis
    Alekseeva, Ekaterina I.
    Denisova, Rina V.
    Valieva, Saniya I.
    Bsarova, Tatyana M.
    Isaeva, Kseniya B.
    Chistyakova, Evgeniya G.
    Sleptsova, Tatyana V.
    Mitenko, Elena V.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2011, 1 (04) : 190 - 198
  • [6] Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (06) : 387 - 397
  • [7] Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)
    Klotsche, Jens
    Niewerth, Martina
    Haas, Johannes-Peter
    Huppertz, Hans-Iko
    Zink, Angela
    Horneff, Gerd
    Minden, Kirsten
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 855 - 861
  • [8] Effect of Tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy
    Miyamae, Takako
    Yokoya, Susumu
    Yamanaka, Hisashi
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2014, 24 (04) : 567 - 571
  • [9] Efficacy and safety of an early response-based tapering regimen of tocilizumab in children with systemic juvenile idiopathic arthritis
    Dey, Soumya
    Roy, Debaditya
    Sinhamahapatra, Pradyot
    Ghosh, Alakendu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (05)
  • [10] Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy
    Toplak, N.
    Avcin, T.
    VACCINE, 2015, 33 (33) : 4056 - 4059